This inventor holds 1 USPTO granted patent and 11 EPO patents. Top assignee: Tokyo Tanabe Company, Ltd.. Active years: 1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1982
Title: Tanaka Yuji: Innovator in Lung Tissue Extracts
Introduction
Tanaka Yuji is a notable inventor based in Toda, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of hyaline-membrane disease. His innovative approach to utilizing lung tissue extracts has opened new avenues for clinical applications.
Latest Patents
Tanaka Yuji holds a patent for a lung tissue extract that is useful for treating hyaline-membrane disease. The patent describes a surface-active material that can be produced from mammalian lung tissue using an acetone-treatment procedure and an organic solvents mixture-treatment procedure. This method differs from conventional techniques such as differential centrifugation, density gradient centrifugation, and dialysis. The active material has a phospholipid content of 75.0-95.5%, a neutral lipid content of 1.8-14.0%, total cholesterol content of 0.0-3.0%, carbohydrate content of 0.1-1.5%, and protein content of 0.5-5.0%, all based on the dried weight of the material. This pharmaceutical composition is particularly useful for the clinical treatment of human hyaline-membrane disease.
Career Highlights
Throughout his career, Tanaka Yuji has worked with prominent companies, including Tokyo Tanabe Company, Ltd. and Kabushiki Kaisha Dnaform. His work has been instrumental in advancing medical treatments and improving patient outcomes.
Collaborations
Tanaka has collaborated with notable individuals in his field, including Fujiwara Tetsuro and Takei Tsunetomo. These collaborations have contributed to the development of innovative solutions in medical science.
Conclusion
Tanaka Yuji's contributions to the field of lung tissue extracts demonstrate his commitment to advancing medical treatments. His innovative patent and collaborations highlight the importance of research and development in addressing critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile